DVA
71
5
QCOM
53
2
GWW
53
7
STT
56
2
PPG
53
4
CHD
43
11
GPC
40
2
HSY
29
-2
CSCO
66
6
IP
53
5
OMC
37
2
GILD
41
3
MAR
51
4
AKAM
34
2
LLY
28
-12
PWR
59
2
HSIC
53
2
HPE
55
4
XRX
45
-3
NI
63
3
DVA
71
5
QCOM
53
2
GWW
53
7
STT
56
2
PPG
53
4
CHD
43
11
GPC
40
2
HSY
29
-2
CSCO
66
6
IP
53
5
OMC
37
2
GILD
41
3
MAR
51
4
AKAM
34
2
LLY
28
-12
PWR
59
2
HSIC
53
2
HPE
55
4
XRX
45
-3
NI
63
3
Financhill
Back

Triumph Financial Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
28

TFIN
Triumph Financial

Last Price:
$87.23
Seasonality Move:
2.72%
Buy
61

ITCI
Intra-Cellular Therapies

Last Price:
$126.86
Seasonality Move:
2.9%
Sell
28
Triumph Financial (TFIN) is a Sell

Is Triumph Financial a Buy, Sell or Hold?

  • The current Triumph Financial [TFIN] share price is $87.25. The Score for TFIN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • TFIN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $126.89. The Score for ITCI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TFIN Stock Price Chart

What is Triumph Financial's stock price today?

  • The Triumph Financial share price today is $87.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $126.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.27 Sell
Relative Strength Index (14 RSI): 38.93 Sell
Chaikin Money Flow: 54992 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.18 - 98.8) Sell
Bollinger Bands (100): (79.75 - 98.75) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.34 Buy
Relative Strength Index (14 RSI): 87.18 Buy
Chaikin Money Flow: -9953478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.29 - 99.79) Buy
Bollinger Bands (100): (72.19 - 89.87) Buy

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.95 Buy
20-day SMA: 90.75 Sell
50-day SMA: 96.57 Sell
200-day SMA: 83.83 Buy
8-day EMA: 87.21 Buy
20-day EMA: 90.59 Sell
50-day EMA: 92.7 Sell
200-day EMA: 85.4 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 95.56 Buy
20-day SMA: 89.05 Buy
50-day SMA: 87.32 Buy
200-day SMA: 76.32 Buy
8-day EMA: 102.15 Buy
20-day EMA: 92.65 Buy
50-day EMA: 87.08 Buy
200-day EMA: 77.64 Buy

Triumph Financial Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and an increase next year of $1.22 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $3.13 per share.

Triumph Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):